Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
20 Mar 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/adaptimmune-questions-viability-after-bringing-cell-therapy-market-cuts-2-preclinical
16 Jan 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/agc-biologics-to-support-adaptimmunes-solid-tumor-cell-therapy/
13 Nov 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/adaptimmune-gears-another-fda-submission-after-hitting-goal-pivotal-sarcoma-study
03 Aug 2024
// PRESS RELEASE
https://www.adaptimmune.com/investors-and-media/news-center/press-releases/detail/271/adaptimmune-receives-u-s-fda-accelerated-approval-of
29 Jul 2024
// BIOSPACE
https://www.biospace.com/drug-development/adaptimmune-gears-up-for-potential-approval-of-first-in-class-engineered-t-cell-therapy
29 Jul 2024
// BIOSPACE
https://www.biospace.com/drug-development/adaptimmune-gears-up-for-potential-approval-of-first-in-class-engineered-t-cell-therapy
ABOUT THIS PAGE